|
|
 |
|
|
|
 |
Richard Bankert, VMD, Ph.D., SUNY Buffalo, professor,
breast cancer research. Will develop a new method for producing cancer
vaccine to eradicate tumors and prevent breast cancer recurrences. |
|
|
 |
Sharon Cantor, Ph.D., U. Mass
Medical School, assistant professor, breast cancer research. Will investigate
a protein, BACH1, that interacts with the breast cancer susceptibility
gene, BRCA1. BACH1 is a helicase, unwinds DNA and may be important
in DNA repair. The study will determine if this protein is altered
in breast cancer. |
|
|
 |
Sudhansu Dey, Ph.D., Vanderbilt Medical Center,
professor, ovarian cancer research. Will investigate the effects of
a nonsteroidal, anti-inflammatory drug to determine (using an animal
model) if it will decrease the risk of ovarian cancer. |
|
|
 |
Leif Ellisen,
Ph.D., Massachusetts General, assistant professor, breast cancer
research. Will use bioinformatics and gene expression profiling to
identify genes regulated by p53 (a critical tumor suppressor that
is altered in almost all cancers). |
|
|
 |
William Holloman, Ph.D., Weill
Medical College of Cornell University, professor, breast cancer research.
Will screen chemical compounds that repair DNA in the absences of a
breast cancer susceptibility gene, BRCA2. This could identify new cancer
prevention strategies. |
|
|
 |
Robert Jaffe,
M.D., UCSF Comprehensive Cancer Center, professor, ovarian cancer
research. Will test a novel cancer therapy involving combining compounds
that prevent blood vascular formation around tumors with a mitosis
inhibitor in an animal model of ovarian cancer. |
|
|
 |
Alessandra Santin, M.D., University
of Arkansas Medical Sciences, assistant professor, ovarian cancer research.
Will investigate a novel therapy for ovarian cancer based on the finding
that ovarian cancer cells express cancer-specific epithelial cell surface
receptors. |
|
|
 |
Richard Schlegel,
M.D., Ph.D., Georgetown University Medical School, professor,
cervical cancer research. Will investigate a Chinese herbal compound,
artemisin, that may kill cervical cancer cells when applied topically. |
|
|
 |
Victoria Seewaldt, M.D., Duke University
School of Medicine, associate professor, breast cancer research. Will
investigate genes involved in vitamin A processing to determine if
their loss is associated with increased risk for developing breast
cancer. |
|
|
 |
Ann Thor,
M.D., Oklahoma University Health Sciences, professor, breast
cancer research. Will test if a synthetic thyroid hormone prescribed
for patients actually promotes breast cancer growth by activation
of the estrogen receptor. |
|
|
|
|